Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other
miscellaneous service companies in Europe:
Brain Biotechnology Research and Information Network AG
sales of 26.42 million Euro [US$30.82 million]
of which 51%
(29.06 million Euro [US$33.91 million]
based in France
(24.41 million Euro [US$28.48 million]
Sales increased substantially in 2017:
During the year ended December of 2017, sales at
Veloxis Pharmaceuticals A/S were 196.99 million Danish Kroner (US$30.81 million).
increase of 217.7%
versus 2016, when the company's sales were 62.00 million Danish Kroner.